These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 18003758)

  • 1. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69.
    Srinivasan S; Bolick DT; Lukashev D; Lappas C; Sitkovsky M; Lynch KR; Hedrick CC
    Diabetes; 2008 Feb; 57(2):484-93. PubMed ID: 18003758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor.
    Whetzel AM; Bolick DT; Srinivasan S; Macdonald TL; Morris MA; Ley K; Hedrick CC
    Circ Res; 2006 Sep; 99(7):731-9. PubMed ID: 16960101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
    Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
    Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of sphingosine 1-phosphate (S1P) receptor type 1 and type 4 in migratory response of mouse T cells toward S1P.
    Matsuyuki H; Maeda Y; Yano K; Sugahara K; Chiba K; Kohno T; Igarashi Y
    Cell Mol Immunol; 2006 Dec; 3(6):429-37. PubMed ID: 17257496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
    Shiow LR; Rosen DB; Brdicková N; Xu Y; An J; Lanier LL; Cyster JG; Matloubian M
    Nature; 2006 Mar; 440(7083):540-4. PubMed ID: 16525420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells.
    Michaud MD; Robitaille GA; Gratton JP; Richard DE
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):902-8. PubMed ID: 19423865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
    Zhang S; Yan X; Zhou PC; Huang C; Yang L; Li X; Lin J; Zhou ZG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):568-72. PubMed ID: 18649776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
    Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
    Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine 1-phosphate promotes antigen processing and presentation to CD4+ T cells in Mycobacterium tuberculosis-infected monocytes.
    Santucci MB; Greco E; De Spirito M; Arcovito G; De Angelis G; Cauda R; Fraziano M
    Biochem Biophys Res Commun; 2007 Sep; 361(3):687-93. PubMed ID: 17673170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
    Qin HY; Chaturvedi P; Singh B
    Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal calf serum-primed dendritic cells induce a strong anti-fetal calf serum immune response and diabetes protection in the non-obese diabetic mouse.
    Kadri N; Potiron N; Ouary M; Jegou D; Gouin E; Bach JM; Lieubeau B
    Immunol Lett; 2007 Feb; 108(2):129-36. PubMed ID: 17196260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development.
    Mori Y; Kodaka T; Kato T; Kanagawa EM; Kanagawa O
    Int Immunol; 2009 Nov; 21(11):1291-9. PubMed ID: 19778991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1.
    Matloubian M; Lo CG; Cinamon G; Lesneski MJ; Xu Y; Brinkmann V; Allende ML; Proia RL; Cyster JG
    Nature; 2004 Jan; 427(6972):355-60. PubMed ID: 14737169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice.
    Bolick DT; Srinivasan S; Kim KW; Hatley ME; Clemens JJ; Whetzel A; Ferger N; Macdonald TL; Davis MD; Tsao PS; Lynch KR; Hedrick CC
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):976-81. PubMed ID: 15761190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.
    Alfonso C; McHeyzer-Williams MG; Rosen H
    Eur J Immunol; 2006 Jan; 36(1):149-59. PubMed ID: 16342326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose poly I:C prevents diabetes in the diabetes prone BB rat.
    Sobel DO; Goyal D; Ahvazi B; Yoon JW; Chung YH; Bagg A; Harlan DM
    J Autoimmun; 1998 Aug; 11(4):343-52. PubMed ID: 9776712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.
    Mehling M; Brinkmann V; Antel J; Bar-Or A; Goebels N; Vedrine C; Kristofic C; Kuhle J; Lindberg RL; Kappos L
    Neurology; 2008 Oct; 71(16):1261-7. PubMed ID: 18852441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant regulation of interleukin-12 receptor beta2 chain on type 1 cytokine-stimulated T lymphocytes in type 1 diabetes.
    Skarsvik S; Ludvigsson J; Vaarala O
    Immunology; 2005 Feb; 114(2):287-93. PubMed ID: 15667574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes.
    Lee IF; Qin H; Priatel JJ; Tan R
    Eur J Immunol; 2008 Jan; 38(1):82-9. PubMed ID: 18085661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.